Finance News – Drugmakers
What is your interest today?
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting close...
Pharmaceutical companies are advancing the development of specialized cancer treatments, potentially reducing reliance on chemotherapy and driving significant market growth through...
Read Full Article →Pharmaceutical stocks slide as Trump vows to cut US prescription drug prices ‘by 30-80%’
The announcement of aggressive measures to lower medication costs in the United States has caused a notable decline in the market value of companies producing pharmaceuticals.
Read Full Article →FTSE 100’s record run fades as pharma stocks slide on new Trump appointment
The decline in major pharmaceutical shares contributed to a modest drop in the FTSE 100, signaling potential market uncertainty linked to changes in US regulatory leadership.
Read Full Article →Americans would suffer most if Trump imposes pharma tariffs, sector warns
Imposing tariffs on pharmaceutical imports could disrupt supply chains and increase medication costs, potentially making essential treatments less accessible for many individuals a...
Read Full Article →Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer...
Eli Lilly experienced a significant increase in sales attributed to strong demand for its weight loss and diabetes medications, yet adjusted its profit forecast following a recent...
Read Full Article →